Skip to main content

Table 2 Liver function markers pre- and post-treatment week 12 (n = 30)

From: Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

 

TBIL, in μmol/L

ALT, in IU/L

ALB, in g/L

PTA, in %

Child-Pugh score

Baseline

23.48 ± 12.54

50.17 ± 32.93

39.52 ± 5.73

76.17 ± 16.80

6.30 ± 1.60

Post-treatment week 12

18.98 ± 9.24

25.70 ± 10.67

42.96 ± 6.17

79.85 ± 14.62

5.87 ± 1.14

t-value

3.371

3.973

4.214

2.544

2.642

p-value

0.002

0.000

0.000

0.017

0.013

  1. ALB albumin, ALT alanine aminotransferase, PTA prothrombin activity, TBIL total bilirubin